Industry News
Promising New Minimally Invasive, MRI-Guided Laser Treatment For Recurrent Glioblastoma
Apr 09, 2013
The first-in-human study of the NeuroBlate™ Thermal Therapy System finds that it appears to provide a new, safe and minimally invasive procedure for treating recurrent glioblastoma (GBM), a malignant type of brain tumor... Read More
Delayed Mammography Screening Can Increase Risk Of Breast Cancer Mortality
Apr 09, 2013
The time between diagnosis of breast cancer among older women and their last mammogram is associated with a heightened risk of breast cancer mortality, according to new data presented at the American Association for Cancer Research (AACR) Annual Meeting 2013. The finding highlights the need for continued mammography screening. Michael S. Simon, M.D., M.P.H... Read More
American College Of Physicians Releases New Prostate Cancer Screening Guidance Statement
Apr 08, 2013
Shared-decision making, clear patient preference recommended before PSA testing Men between the ages of 50 and 69 should discuss the limited benefits and substantial harms of the prostate-specific antigen (PSA) test with their doctor before undergoing screening for prostate cancer, according to new recommendations issued today by the American College of Physicians (ACP)... Read More
Research Letter, Viewpoint, Invited Commentary Examine Cervical Cancer Screening Intervals
Apr 08, 2013
JAMA Internal Medicine Study Highlights A research letter by Zahava Berkowitz, M.S.P.H., M.Sc., of the Centers for Disease Control and Prevention, and colleagues found that most of the 2,087 primary care clinicians surveyed recommended Papanicolaou (pap) tests sooner than recommended by guidelines after co-testing for the human papillomavirus (HPV)... Read More
Personalized Ovarian Cancer Vaccine Shows Promise In Trial
Apr 08, 2013
Delegates at a conference in the US this week are hearing about early results of a trial of a new personalized ovarian cancer vaccine that offers new hope for the large number of patients who relapse after treatment... Read More
Common Heart Drug Associated With Increased Cancer Risk
Apr 08, 2013
A drug known as amiodarone, used to treat heartbeat irregularities, could raise a person's cancer risk, according to new research published in the journal Cancer. The study reveals that the risk, which the investigators described as "borderline significantly increased", is more prevalent in men and people who take greater doses of amiodarone... Read More
In An Animal Model Of Ovarian Cancer, Engineered T Cells Kill Tumors But Spare Normal Tissue
Apr 08, 2013
The need to distinguish between normal cells and tumor cells is a feature that has been long sought for most types of cancer drugs. Tumor antigens, unique proteins on the surface of a tumor, are potential targets for a normal immune response against cancer. Identifying which antigens a patient's tumor cells express is the cornerstone of designing cancer therapy for that individual... Read More
Some Women With HIV Become Infected By Cancer-Causing Forms Of HPV That Are Not Covered By Current Vaccines
Apr 08, 2013
Women with HIV acquire cancer-causing forms of the human papillomavirus (HPV) that are not included in the current HPV vaccines Gardasil and Cervarix, according to new research from Fox Chase Cancer Center presented at the AACR Annual Meeting 2013 on Sunday, April 7... Read More
Cells From Patients' Blood Could Be Developed As Treatments For Blood, Heart And Circulatory Diseases
Apr 08, 2013
Scientists have shed light on a common bleeding disorder by growing and analysing stem cells from patients' blood to discover the cause of the disease in individual patients. The technique may enable doctors to prescribe more effective treatments according to the defects identified in patients' cells... Read More
Arrhythmia Drug May Increase Cancer Risk
Apr 08, 2013
One of the most widely used medications to treat arrhythmias may increase the risk of developing cancer, especially in men and people exposed to high amounts of the drug. That is the conclusion of a new retrospective study published early online in CANCER, a peer-reviewed journal of the American Cancer Society... Read More
Previous Page Next Page